A Case Report of Hemicrania Continua‐Like Headache Due to Ipsilateral Inflammatory Orbital Pseudotumor

DeLange, Justin M.; Robertson, Carrie E.; Krecke, Karl N.; Garza, Ivan

doi:10.1111/head.12440

Cited by 5 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We identified seven cases [ 28 , 32 – 35 ] of symptomatic hemicrania continua of whom one was excluded as the patient did not receive indomethacin [ 28 ]. We categorized two cases as probably symptomatic , three as possibly symptomatic , and one as unknown (Table 2 ).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Symptomatic Trigeminal Autonomic Cephalalgias

Coo

Wilbrink

Haan

2015

Curr Pain Headache Rep

View full text Add to dashboard Cite

Trigeminal autonomic cephalalgias (TACs) are primary headache syndromes that share some clinical features such as a trigeminal distribution of the pain and accompanying ipsilateral autonomic symptoms. By definition, no underlying structural lesion for the phenotype is found. There are, however, many descriptions in the literature of patients with structural lesions causing symptoms that are indistinguishable from those of idiopathic TACs. In this article, we review the recent insights in symptomatic TACs by comparing and categorizing newly published cases. We confirm that symptomatic TACs can have typical phenotypes. It is of crucial importance to identify symptomatic TACs, as the underlying cause will influence treatment and outcome. Our update focuses on when a structural lesion should be sought.

show abstract

Section: Resultsmentioning

confidence: 99%

“…One case was classified as unknown . This patient was diagnosed with an orbital pseudotumour, treated with prednisone and indomethacin [ 32 ].…”

Section: Resultsmentioning

confidence: 99%

Symptomatic Trigeminal Autonomic Cephalalgias

Coo

Wilbrink

Haan

2015

Curr Pain Headache Rep

View full text Add to dashboard Cite

show abstract

“…When the patient took IMC 25 mg t.i.d., she had complete resolution of her pain. Authors concluded that orbital pseudotumor should be considered as an HC mimic …”

Section: Secondary Headaches Responsive To Imcmentioning

confidence: 99%

Indomethacin Responsive Headaches: Exhaustive Systematic Review With Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies

Bordini

Bordini²,

Woldeamanuel

et al. 2016

Headache

View full text Add to dashboard Cite

The "velocity" of publications on IMC and headache seems to be decreasing, particularly on the use of IMC for the treatment of TACs. The science behind the understanding of the putative mechanisms of IMC's action on headache has moved forward, but the answer to why it works better than other nonsteroidal anti-inflammatory drugs has been elusive. There are case reports of other rare headache disorders that may be responsive to IMC. The dosages of IMC used as a tool for detecting IMC responsive disorders vary according to different centers of investigation. In many circumstances, headache disorders similar to "primary" IMC-responsive disorders are actually symptomatic disorders. Cluster headache as an IMC-resistant headache disorder may not be as absolute as once thought. Sometimes, IMC has been found to provoke headache; differentiating IMC-provoked headache from IMC-resistant headache can make headache diagnosis and management difficult. As for the "absolute" responsiveness of IMC, it is possible that using higher dosages leads to higher sensitivity, probably at the expense of decreased specificity. There are many reports about the occurrence of two or more IMC-responsive disorders (latu sensu) in the same patient, which may be coincidental.

show abstract

“…The increasing number of HC symptomatic cases, from 9 in the period 1984‐2001 to 17 in 2001‐2009, should be related to the formal recognition of this headache, which first appeared in the second edition of ICHD . Since the publication of the last review in 2009, five further symptomatic cases have been described . Up until now, no cases of HC induced by medication have been described.…”

mentioning

confidence: 99%

Hemicrania Continua‐Like Headache Related to Transdermal Nitroglycerine Therapy

2016

View full text Add to dashboard Cite

Several cases of symptomatic hemicrania continua (HC) have been reported. A 66-year-old man, suffering from migraine without aura, presented with a four month history of a new headache fulfilling the ICHD 3beta clinical criteria for HC. HC onset was strictly related to the use of transdermal nitroglycerine patch (TNP). In agreement with the cardiologist, TNP was discontinued and the headache promptly disappeared; symptoms reappeared within 6-12 hours after nitroglycerine reintroduction. After permanent discontinuation of TNP, headache disappeared at one year follow-up. To the best of our knowledge, this is the first report of the occurrence of an HC-like headache related to TNP.

show abstract

A Case Report of Hemicrania Continua‐Like Headache Due to Ipsilateral Inflammatory Orbital Pseudotumor

Cited by 5 publications

References 4 publications

Symptomatic Trigeminal Autonomic Cephalalgias

Symptomatic Trigeminal Autonomic Cephalalgias

Indomethacin Responsive Headaches: Exhaustive Systematic Review With Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies

Hemicrania Continua‐Like Headache Related to Transdermal Nitroglycerine Therapy

Contact Info

Product

Resources

About